Lauren White C4 Therapeutics, Inc. (CCCC) insider trading activity

CCCC Quotes by TradingView

Lauren White is Chief Financial Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 32,686 shares of CCCC, which is worth approximately $190,559. The most recent transaction as insider was on Aug 30, 2023, when has been sold 661 shares (Common Stock) at a price of $2.93 per share, resulting in proceeds of $1,936. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.7K
0% 3M change
0% 12M change
Total Value Held $190,559

Lauren White Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2023
SELL
Payment of exercise price or tax liability
$1,936 $2.93 p/Share
661 Reduced 1.98%
32,686 Common Stock
Aug 30 2023
BUY
Exercise of conversion of derivative security
-
2,250 Added 6.32%
33,347 Common Stock
Feb 13 2023
BUY
Grant, award, or other acquisition
-
26,000 Added 45.54%
31,097 Common Stock
Jan 30 2023
SELL
Payment of exercise price or tax liability
$10,121 $7.78 p/Share
1,301 Reduced 20.33%
5,097 Common Stock
Jan 30 2023
BUY
Exercise of conversion of derivative security
-
3,750 Added 36.95%
6,398 Common Stock
May 25 2022
BUY
Exercise of conversion of derivative security
-
3,750 Added 50.0%
3,750 Common Stock

Also insider at

IMGN
ImmunoGen, Inc. Healthcare
SVP, CFO AND PFO
LW

Lauren White

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CCCC